| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |